Evidence map›Paper›PMID 22854971›Full record

ArticleThe Journal of biological chemistry2012

Phosphatidylethanolamine binding is a conserved feature of cyclotide-membrane interactions.

Sónia Troeira Henriques, Yen-Hua Huang, Miguel A R B Castanho, Luis A Bagatolli, Secondo Sonza, Gilda Tachedjian, Norelle L Daly, David J Craik

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed
5.1field-weighted citation impact, top 4% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 135 citations in OpenAlex.

  1. Effects of Selenocysteine Substitution on the Cyclotide Kalata B2.Chembiochem : a European journal of chemical biology · 2026
    Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Protein and peptide letters · 2024
    Article
  10. Review
  11. Article
  12. Article
  13. Frontiers in pharmacology · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Review
  18. Membrane-Interacting Antifungal Peptides.Frontiers in cell and developmental biology · 2021
    Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 3 countries.

Sónia Troeira HenriquesInstitute for Molecular Bioscience, The University of Queensland, Brisbane, 4072 Queensland, Australia.
Yen-Hua Huang
Miguel A R B Castanho
Luis A Bagatolli
Secondo Sonza
Gilda Tachedjian
Norelle L Daly
David J Craik
University of Queensland · AUMonash University · AUUniversity of Lisbon · PTUniversity of Southern Denmark · DK

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Cyclotides are bioactive cyclic peptides isolated from plants that are characterized by a topologically complex structure and exceptional resistance to enzymatic or thermal degradation. With their sequence diversity, ultra-stable core structural motif, and range of bioactivities, cyclotides are regarded as a combinatorial peptide template with potential applications in drug design. The mode of action of cyclotides remains elusive, but all reported biological activities are consistent with a mechanism involving membrane interactions. In this study, a diverse set of cyclotides from the two major subfamilies, Möbius and bracelet, and an all-d mirror image form, were examined to determine their mode of action. Their lipid selectivity and membrane affinity were determined, as were their toxicities against a range of targets (red blood cells, bacteria, and HIV particles). Although they had different membrane-binding affinities, all of the tested cyclotides targeted membranes through binding to phospholipids containing phosphatidylethanolamine headgroups. Furthermore, the biological potency of the tested cyclotides broadly correlated with their ability to target and disrupt cell membranes. The finding that a broad range of cyclotides target a specific lipid suggests their categorization as a new lipid-binding protein family. Knowledge of their membrane specificity has the potential to assist in the design of novel drugs based on the cyclotide framework, perhaps allowing the targeting of peptide drugs to specific cell types.

Indexed as

Amino Acid SequenceAnti-HIV AgentsCell MembraneChemistry, PharmaceuticalConserved SequenceCyclotidesDrug DesignErythrocytesHemolysisHumansLipid BilayersLipidsModels, MolecularMolecular ConformationMolecular Sequence DataPeptidesAnti-HIV AgentsCyclotidesLipid BilayersLipidsPeptidesphosphatidylethanolaminePhosphatidylethanolamines

Identifiers

PMID22854971
PMCPMC3460461
OpenAlexW2033508868

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.